Role of the JAK/STAT signaling pathway in diabetic nephropathy
- PMID: 16527921
- DOI: 10.1152/ajprenal.00181.2005
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Abstract
Excessive cellular growth is a major contributor to pathological changes associated with diabetic nephropathy. In particular, high glucose-induced growth of glomerular mesangial cells is a characteristic feature of diabetes-induced renal complications. Glomerular mesangial cells respond to traditional growth factors, although in diabetes this occurs in the context of an environment enriched in both circulating vasoactive mediators and high glucose. For example, the vasoactive peptide ANG II has been implicated in the pathogenesis of diabetic renal disease, and recent findings suggest that high glucose and ANG II activate intracellular signaling processes, including the polyol pathway and generation of reactive oxygen species. These pathways activate the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling cascades in glomerular mesangial cells. Activation of the JAK/STAT signaling cascade can stimulate excessive proliferation and growth of glomerular mesangial cells, contributing to diabetic nephropathy. This review focuses on some of the key elements in the diabetic microenvironment, especially high glucose and the accumulation of advanced glycoxidation end products and considers their impact on ANG II and other vasoactive peptide-mediated signaling events in vitro and in vivo.
Similar articles
-
Angiotensin II-induced signaling pathways in diabetes.Curr Diabetes Rev. 2005 May;1(2):197-202. doi: 10.2174/1573399054022802. Curr Diabetes Rev. 2005. PMID: 18220595 Review.
-
Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.Nephrology (Carlton). 2005 Oct;10 Suppl:S7-10. doi: 10.1111/j.1440-1797.2005.00448.x. Nephrology (Carlton). 2005. PMID: 16174288 Review.
-
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.Eur J Clin Invest. 2004 Dec;34(12):785-96. doi: 10.1111/j.1365-2362.2004.01429.x. Eur J Clin Invest. 2004. PMID: 15606719 Review.
-
JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases.Vascul Pharmacol. 2005 Nov;43(5):357-63. doi: 10.1016/j.vph.2005.08.021. Epub 2005 Nov 3. Vascul Pharmacol. 2005. PMID: 16271517 Review.
-
Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.J Mol Cell Cardiol. 1997 Nov;29(11):2893-902. doi: 10.1006/jmcc.1997.0524. J Mol Cell Cardiol. 1997. PMID: 9405164 Review.
Cited by
-
Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.Sci Rep. 2016 Sep 16;6:33676. doi: 10.1038/srep33676. Sci Rep. 2016. Retraction in: Sci Rep. 2024 Apr 2;14(1):7734. doi: 10.1038/s41598-024-58326-x PMID: 27633396 Free PMC article. Retracted.
-
Exploring the pathogenesis of diabetic kidney disease by microarray data analysis.Front Pharmacol. 2022 Aug 17;13:932205. doi: 10.3389/fphar.2022.932205. eCollection 2022. Front Pharmacol. 2022. PMID: 36059966 Free PMC article.
-
Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling.Front Endocrinol (Lausanne). 2019 Jul 3;10:441. doi: 10.3389/fendo.2019.00441. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31333586 Free PMC article.
-
JAK/STAT signaling in diabetic kidney disease.Front Cell Dev Biol. 2023 Aug 11;11:1233259. doi: 10.3389/fcell.2023.1233259. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37635867 Free PMC article. Review.
-
Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy.Lab Invest. 2011 Apr;91(4):488-98. doi: 10.1038/labinvest.2010.188. Epub 2010 Nov 22. Lab Invest. 2011. PMID: 21102505 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
